51 terminated. 51 Phase 2, 11 Phase 3, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 51 | Terminated 51 |
| Phase 3 | 11 | Terminated 11 |
| Phase 1 | 7 | Terminated 7 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack BI 765845, Placebo matching BI 765845 - Myocardial Infarction | Phase 2 | Terminated | Boehringer Ingelheim | 160 | 2023-12-05 | 2026-07-27 |
| The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study PICSO - Myocardial Infarction | Phase 2 | Terminated | Oxford University Hospitals NHS Trust | 2 | 2021-08-03 | 2023-08-21 |
| Prevention of Acute Kidney Injury in Patients With NSTEMI conestat alfa or placebo - Non-ST Elevation Myocardial Infarction (NSTEMI) | Phase 2 | Terminated | Pharming Technologies B.V. | 29 | 2021-04-21 | 2024-04-03 |
| YQ23 Study in Patients With Critical Limb Ischaemia YQ23, Matching placebo - Critical Limb Ischemia | Phase 1 / Phase 2 | Terminated | New Beta Innovation Limited | 5 | 2021-03-10 | 2023-12-08 |
| SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial Definity® with High Mechanical Index Ultrasound - ST Elevation Myocardial Infarction | Phase 2 | Terminated | University of Alberta | 41 | 2021-02-23 | 2026-03-04 |
| COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction Colchicine - Myocardial Infarction, Acute | Phase 2 / Phase 3 | Terminated | University Hospital, Montpellier | 54 | 2020-12-04 | 2026-06-12 |
| Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 Rivaroxaban, Standard Of Care (SOC) - COVID-19 | Phase 2 | Terminated | Charite University, Berlin, Germany | 111 | 2020-11-30 | 2022-01-12 |
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Pemziviptadil (PB1046), Low Dose (10 mg) Control - Acute Respiratory Distress Syndrome, Coronavirus | Phase 2 | Terminated | PhaseBio Pharmaceuticals Inc. | 54 | 2020-07-15 | 2020-12-11 |
| Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia. Autologous ASC (for Adipose-derived Stem/Stroma Cell) - Critical Limb Ischemia and Peripheral Artery Disease | Phase 2 | Terminated | University Hospital, Toulouse | 2 | 2020-03-04 | 2023-03-31 |
| SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy Dual Antiplatelet (DAPT) Therapy, The Synergy® stent - Coronary Artery Disease, Atherosclerosis | Phase 2 | Terminated | HonorHealth Research Institute | 50 | 2018-11-19 | 2024-12-27 |
| Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI Entresto Pill - Myocardial Infarction, Diastolic Dysfunction | Phase 2 | Terminated | Jacob Moller | 51 | 2018-10-12 | 2025-01-29 |
| Investigation of Neural Stem Cells in Ischemic Stroke CTX0E03 Drug Product and delivery device, Placebo - Ischemic Stroke, Chronic Stroke | Phase 2 | Terminated | ReNeuron Limited | 15 | 2018-08-31 | 2021-08-13 |
| Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI Methotrexate, Placebo, Folic Acid - Myocardial Infarction, Anterior Wall, Myocardial Remodeling, Ventricular | Phase 2 / Phase 3 | Terminated | University of Sao Paulo | 35 | 2018-04-17 | 2021-01-11 |
| DNS-3379 vs. Placebo in Stroke Rehabilitation DNS-3379, Placebo - Ischemic Stroke | Phase 2 | Terminated | Dart NeuroScience, LLC | 1 | 2017-11-13 | 2018-02-01 |
| A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke Basmisanil, Placebo - Stroke | Phase 2 | Terminated | Hoffmann-La Roche | 5 | 2017-02-20 | 2019-01-02 |
| Effect of DLBS1033 After Primary PCI in Patients With STE-ACS DLBS1033, Placebo, Standard therapy - ST Elevation Myocardial Infarction | Phase 2 / Phase 3 | Terminated | Dexa Medica Group | 23 | 2016-11-01 | 2023-09-08 |
| Plerixafor in Diabetic Wound Healing Plerixafor, Placebo - Diabetes, Wounds | Phase 2 | Terminated | Gian Paolo Fadini | 25 | 2016-06-01 | 2019-12-19 |
| HT-3951 vs. Placebo in Stroke Rehabilitation HT-3951, Placebo - Ischemic Stroke | Phase 2 | Terminated | Dart NeuroScience, LLC | 61 | 2016-02-01 | 2018-02-01 |
| A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction AMI MultiStem cells, Sham - Heart Attack, NSTEMI | Phase 2 | Terminated | Healios K.K. | 34 | 2015-12-01 | 2021-07-22 |
| Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR Ticagrelor, Comparator - Peripheral Artery Disease (PAD) | Phase 2 | Terminated | AstraZeneca | 40 | 2014-10-20 | 2017-07-19 |
Showing 20 of 51. Sign in to see all of them.
Myocardial Infarction (21) · Stroke (9) · Chronic Limb-Threatening Ischemia (7) · ST Elevation Myocardial Infarction (7) · Cardiovascular Diseases (5) · Coronary Artery Disease (5) · Heart Diseases (5) · Peripheral Vascular Diseases (5) · Heart Failure (4) · Ischemic Stroke (4) · Cerebral Infarction (3) · Cerebrovascular Disorders (3) · Infarction, Middle Cerebral Artery (3) · Non-ST Elevated Myocardial Infarction (3)
Pathologic Processes (51) · Pathological Conditions, Signs and Symptoms (51) · Vascular Diseases (46) · Cardiovascular Diseases (44) · Infarction (38) · Necrosis (38) · Myocardial Ischemia (30) · Heart Diseases (27) · Arterial Occlusive Diseases (13) · Arteriosclerosis (13) · Central Nervous System Diseases (11) · Brain Diseases (10) · Myocardial Infarction (10) · Nervous System Diseases (10)
Saline Solution (4) · Endothelium-Dependent Relaxing Factors (2) · Nitrogen (2) · Standard of Care (2) · Ticagrelor (2) · 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Aspirin (1) · Atorvastatin (1) · Clopidogrel (1) · Colchicine (1) · Cool-Down Exercise (1) · Corn Oil (1) · DLBS 1033 (1) · Eptifibatide (1) · Fish Oils (1)
Mallinckrodt (3) · Dart NeuroScience, LLC (2) · Johann Wolfgang Goethe University Hospital (2) · Alexion Pharmaceuticals, Inc. (1) · Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1) · Angion Biomedica Corp (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Biopure Corporation (1) · Boehringer Ingelheim (1) · Brigham and Women's Hospital (1) · Capricor Inc. (1) · Celularity Incorporated (1) · Charite University, Berlin, Germany (1) · Cook MyoSite (1)
United States (21) · Canada (8) · France (4) · Germany (4) · Spain (4) · Australia (3) · Poland (3) · South Korea (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Denmark (2) · Italy (2) · New Zealand (2) · Switzerland (2)
Andreas M Zeiher, MD (2) · A. Gerson Greenburg, MD, Ph.D. (1) · Aline G. Ferrari, MD (1) · Andrew P Levy, MD PhD (1) · Anurag Relan, MD (1) · Bernat Soria (1) · Billy Lau (1) · C. Michael Gibson, M.D. (1) · Chen Shapira, MD (1)
PMID 15016484, PMID 16990385, PMID 18032779, PMID 19958867, PMID 20185783, PMID 22936827, PMID 23362308, PMID 23686372, PMID 24152824, PMID 26483108, PMID 27834742, PMID 29629845, PMID 32749459, PMID 33502773, PMID 34233913, PMID 34538132, PMID 35130557, PMID 35244208, PMID 37740111, PMID 38289979, PMID 38419030, PMID 41541089
2015 (1), P50NS044148 (1), P50NS044227 (1), R01NS037666 (1), R01NS045170 (1), R44HL091699 (1), R44HL117572 (1), RC3HL103356-01 (1)